Patent · US Active

Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor

US9265843B2 · kind B2 · utility

4Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2009
Grant dateFeb 23, 2016
Priority date—
Expiry dateApr 8, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein is a system which uses a gene therapy particle that includes at least one gene, cDNA, fragment or analogue of at least one neurotropin that binds to the trkB receptor or the trkB receptor itself. The gene therapy particle is capable of being delivered to a subject in need thereof for therapy of a metabolic disorder. In a particular aspect, this invention is directed to an inventive method that demonstrates a remarkable efficacy on lowering body weight.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.